Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Sigma Pharmaceuticals partners with BoxxDocks to boost efficiency and sustainability

Sigma Pharmaceuticals partners with BoxxDocks to boost efficiency and sustainability

Through this partnership, Sigma aims to bolster its ESG strategy and accelerate its commitment to NHS net zero objectives

Sigma Pharmaceuticals, a leading pharmacy wholesaler and distributor in the UK, has joined hands with logistics technology innovator, BoxxDocks, to enhance efficiency and sustainability across its warehouse and transport operations.


Through this collaboration, Sigma will pioneer the use of BoxxDocks' cutting-edge tracking technology in the pharmaceutical sector, thereby improving asset visibility and management, a first-of-its-kind initiative in the industry.

Considered to be the first of its kind in the supply chain and logistics industry, BoxxDocks’ technology offers data-driven, granular track and trace solutions that “not only addresses the critical issue of inventory loss but also paves the way for cost savings and environmental benefits.”

By providing real-time data on asset location and movement, it empowers B2B distributors to “map their entire supply chains with unprecedented accuracy and efficiency.” This capability can significantly enhance operational efficiency and reduce costs by optimising asset utilisation and minimising loss, the company noted.

Rajiv Shah, Procurement and Innovation Officer at Sigma, said that the partnership with BoxxDocks will help accelerate their commitment to sustainability and achieving NHS net zero objectives.

“By having the ability to track our assets, we'll be able to minimise our environmental footprint by significantly reducing single-use materials, cutting down on the use of disposable packaging, while streamlining our distribution processes,” he added.

Additionally, BoxxDocks' innovative tracking technology enhances transit security and reduces waste by promoting reusable assets over single-use materials, thereby cutting environmental and financial impacts.

BoxxDocks CEO Alessandro Attanzio emphasised that their mission is to help enhance B2B distribution by offering smart, sustainable and cost-saving solutions.

He said: “We’re delighted to be working with Sigma Pharmaceuticals, which is a forward-thinking company with a passion for innovation that rivals our own. We look forward to continuing our journey of innovation together, demonstrating a model of best practice for pharma distribution.”

By partnering with Sigma, Attanzio said they have further refined their technology to meet the specific needs of the pharmaceutical sector.

Attanzio reiterated that their technology can “transform operations, reduce cost and environmental impact, and help drive the industry forward to meet efficiency and sustainability goals.”

More For You

Chemotherapy-free leukaemia treatment

The trial found that a combination of two cancer drugs, ibrutinib and venetoclax, could perform better than chemotherapy among patients with chronic lymphocytic leukaemia.

iStock

Chemotherapy-free leukaemia treatment shows promise during trial

In a breakthrough in leukaemia research, scientists in the UK have tested a chemotherapy-free approach, involving a combination of targeted drugs, which may offer better outcomes.

The new treatment could radically change the way chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in adults, is treated.

Keep ReadingShow less
Locum pharmacists in the UK work in a difficult environment, and many are dissatisfied with their jobs.

Locum pharmacists in the UK work in a difficult environment, and many are dissatisfied with their jobs.

iStock

Locums should stand up for their interests, say 'no' to unfair terms: PDA

The Pharmacists' Defence Association (PDA) has advised locum pharmacists to be vigilant about their interests and negotiate directly with their businesses, avoid working with digital platforms driven by algorithms, and be aware of regressive contract terms.

The not-for-profit organisation issued such an advisory following its survey of 1,300 UK locum pharmacists, which showed that they work in a difficult environment and that most are dissatisfied with their jobs.

Keep ReadingShow less
Wales ranked worst for second-trimester abortion access in the UK

Each year about 175 women travel from Wales to England for care

Wales ranked worst for second-trimester abortion access in the UK

A leading healthcare charity has revealed that Wales is the worst part of the United Kingdom for allowing surgical abortions for women.

Surgical abortion is the process removing pregnancy from the womb by inducing local anaesthesia, conscious sedation or general anaesthesia.

Keep ReadingShow less
The fund offers £150 per eligible child - for up to three children per household.

The fund offers £150 per eligible child - for up to three children per household.

Charity reopens funding to ease back to school financial pressures for community pharmacists

Community pharmacists struggling with the costs of their children going back to school can apply for funding from The Leverhulme Trade Charities Trust (LTCT)

The Trust is providing up to £100,000 of support to those working in a community pharmacy or are a registered pharmacist or pharmacy technician

Keep ReadingShow less
Germany's BioNTech to buy CureVac to boost cancer research

Both biotech companies have been working for years in the area of mRNA vaccines and treatments

Germany's BioNTech to buy CureVac to boost cancer research

Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, bringing together two pharmaceutical firms specialised in mRNA technology with the goal of advancing cancer treatments.

BioNTech, which developed the first coronavirus vaccine to be approved in the West along with US pharmaceutical giant Pfizer, said the acquisition would "bring together complementary capabilities and leverage technologies".

Keep ReadingShow less